Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial
- PMID: 28710339
- PMCID: PMC5738533
- DOI: 10.1136/thoraxjnl-2016-209690
Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial
Abstract
Background: Smoking cessation was examined among high-risk participants in the UK Lung Cancer Screening (UKLS) Pilot Trial of low-dose CT screening.
Methods: High-risk individuals aged 50-75 years who completed baseline questionnaires were randomised to CT screening (intervention) or usual care (no screening control). Smoking habit was determined at baseline using self-report. Smokers were asked whether they had quit smoking since joining UKLS at T1 (2 weeks after baseline scan results or control assignment) and T2 (up to 2 years after recruitment). Intention-to-treat (ITT) regression analyses were undertaken, adjusting for baseline lung cancer distress, trial site and sociodemographic variables.
Results: Of a total 4055 individuals randomised to CT screening or control, 1546 were baseline smokers (759 intervention, 787 control). Smoking cessation rates were 8% (control n=36/479) versus 14% (intervention n=75/527) at T1 and 21% (control n=79/377) versus 24% (intervention n=115/488) at T2. ITT analyses indicated that the odds of quitting among screened participants were significantly higher at T1 (adjusted OR (aOR) 2.38, 95% CI 1.56 to 3.64, p<0.001) and T2 (aOR 1.60, 95% CI 1.17 to 2.18, p=0.003) compared with control. Intervention participants who needed additional clinical investigation were more likely to quit in the longer term compared with the control group (aOR 2.29, 95% CI 1.62 to 3.22, p=0.007) and those receiving a negative result (aOR 2.43, 95% CI 1.54 to 3.84, p<0.001).
Conclusions: CT lung cancer screening for high-risk participants presents a teachable moment for smoking cessation, especially among those who receive a positive scan result. Further behavioural research is needed to evaluate optimal strategies for integrating smoking cessation intervention with stratified lung cancer screening.
Trial registration number: Results, ISRCTN 78513845.
Keywords: Lung Cancer; Smoking cessation.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Conflict of interest statement
Competing interests: None declared.
Figures
Comment in
-
Does a lung cancer screening programme promote smoking cessation?Thorax. 2017 Oct;72(10):870-871. doi: 10.1136/thoraxjnl-2017-210621. Epub 2017 Jul 26. Thorax. 2017. PMID: 28747323 No abstract available.
-
Challenges of quitting smoking and lung cancer screening.Ann Transl Med. 2017 Dec;5(24):488. doi: 10.21037/atm.2017.09.40. Ann Transl Med. 2017. PMID: 29299450 Free PMC article. No abstract available.
References
-
- World Lung Foundation/American Cancer Society. The tobacco atlas. http://www.tobaccoatlas.org (accessed 18 Mar 2016).
-
- Cancer Research UK. Lung cancer risk factors. http://www.cancerresearchuk.org/health-professional/cancer-statistics/st... (accessed 18 Mar 2016).
-
- ASH. Smoking statistics. http://www.ash.org.uk/files/documents/ASH_93.pdf (accessed 18 Mar 2016).
-
- ASH. Smoking statistics: who smokes and how much. http://ash.org.uk/files/documents/ASH_106.pdf (accessed 18 Mar 2016).
-
- Office for National Statistics. Do smoking rates vary between more and less advantaged areas? http://www.ons.gov.uk/ons/rel/disability-and-health-measurement/do-smoki... (accessed 18 Mar 2016).
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical